AML Flashcards
Median age AML
65 yo (rare in general, mostly elderly)
Risk factors AML
benzene, XRT, Downs, prior chemo (sp etoposide and alkylating agents), Faconi, Diamond Blackfan
What is Sweet syndrome
Inflammatory rxn with fever and painful violaceous scutaneous lesions
How can a pt be diagnosed
- Genetics
or
2a. 20%+ blasts in marrow or peripheral blood AND
2b. Myeloid origin proven by Auer rods or flow cyometry
Defining genetic mutations for AML
t(8,21)
inv(16)
t (16,16)
t(15,17)
What’s the general name of test for molecular markers?
Rapid heme panel testing
Poor prognostic markers
Mutations:
FLT3-ITD
RUNX1/ASXL1/TP53
Induction Tx: <60 yo
Induction with goal of CR
“7+3”: cytarabine cont infusion x 7d; daunorubicin bolus on d1-3
Check BMBx @ d14 w/ goal of <5% blasts, if not, re-induce with 5+2
2nd line tx: <60
HiDAC
1st line consolidation tx <60 yo
Goal: Eliminate undetectable residual dz.
3-4 cycles HiDAC.
Adverse risk consolidation tx
allo HCT
What tx would you add to induction if FLT3 positive
midostaurin
1st line consolidation tx >60 yo
“5+2” cytarabine + daunorubicin or IDAC
Onc emergency that occurs early in consolidation tx when pt has high WBC
TLS
Older pt not eligible for chemo tx
Venetoclax + hypomethylating agent